Oct
2026
Fiera Milano, Italy
Visit us
stand 7H43, Integrated Pharma

Biosidus

Exhibitor at CPHI Milan 2026
About Us

Biosidus is dedicated to the development, manufacturing, and commercialization of high-quality recombinant proteins and biosimilars. Since launching Erythropoietin in 1990, the company has successfully introduced Interferon Alfa 2a, Interferon Alfa 2b, Filgrastim, Somatropin, Lenograstim, Azacitidine, Bortezomib, Interferon Beta 1a (SC and IM), and Teriparatide. In 2025, Biosidus expanded its portfolio with the launch of Agalsidase. Today, Biosidus products are commercialized in more than 50 markets worldwide.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Argentina
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Primary activities
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 7H43, Integrated Pharma

Products Featured at CPHI Milan 2026

  • Agalzyme

    Product Agalzyme

    Agalsidase beta is indicated as long-term enzyme replacementtherapyin patients with a confirmed diagnosis of Fabry disease(alpha-galactosidase A deficiency).
    The product is developed and produced in Argentina following ICH regulations. Therapeutic bioequivalence, eficacy and safety comparable to the r...
  • Neutromax 30 M I.U./ 48 M I.U.

    Product Neutromax 30 M I.U./ 48 M I.U.

    Filgrastim is a recombinant methionyl human granulocyte colony stimulating factor (r-Met-Hu-GCSF), produced by bacterial fermentation. Filgrastim is used to treat neutropenia, a side effect of chemotherapy, which makes patients more susceptible to bacterial infections.
    Biosidus Filgrastim product is av...
  • Hemax 1.000/2.000/3.000/4.000/10.000/20.000/40.000 IU

    Product Hemax 1.000/2.000/3.000/4.000/10.000/20.000/40.000 IU

    Hemax is a synthetic form of human erythropoietin, used to treat anemia. Biosidus recombinant human erythropoietin, our flagship product, is obtained by mass cell culture of genetically modified mammalian cells. Our epoetin is available in a convenient thermostable formulation as freeze dried powder for in...
  • HHT 4 I.U/16 I.U. / HHT PEN 60 I.U.

    Product HHT 4 I.U/16 I.U. / HHT PEN 60 I.U.

    Somatropin is a sinthetic version of human growth hormone (hGH) which stimulates growth and cell reproduction in humans, also exerting its action on the metabolism of lipids, proteins and carbohydrates. Recombinant hGH (also known as somatropin) is produced by bacterial fermentation.
    Somatropin Biosidu...
  • Blastoferon 22/44 mcg

    Product Blastoferon 22/44 mcg

    Blastoferon is a recombinant human interferon, produced by mammalian mass cell culture technology. Interferon beta 1a is indicated for the treatment of relapsing recurrent multiple sclerosis.
    Blastoferon product is available as a pre-filled syringe solution ready for subcutaneous injection and comes in...

Biosidus S.A.U. Resources (1)